A detailed history of Parallel Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,347 shares of MRNA stock, worth $132,507. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,347
Previous 4,249 21.23%
Holding current value
$132,507
Previous $504,000 55.75%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $57,403 - $112,876
-902 Reduced 21.23%
3,347 $223,000
Q2 2024

Aug 08, 2024

SELL
$101.21 - $166.61 $117,707 - $193,767
-1,163 Reduced 21.49%
4,249 $504,000
Q1 2024

May 06, 2024

BUY
$85.37 - $115.44 $138,640 - $187,474
1,624 Added 42.87%
5,412 $576,000
Q4 2023

Feb 09, 2024

SELL
$69.51 - $104.43 $133,598 - $200,714
-1,922 Reduced 33.66%
3,788 $376,000
Q3 2023

May 20, 2024

SELL
$96.41 - $126.61 $24,102 - $31,652
-250 Reduced 4.19%
5,710 $589,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $24,102 - $31,652
-250 Reduced 4.19%
5,710 $589,000
Q2 2023

May 20, 2024

SELL
$118.5 - $160.53 $60,198 - $81,549
-508 Reduced 7.85%
5,960 $724,000
Q2 2023

Aug 04, 2023

SELL
$118.5 - $160.53 $60,198 - $81,549
-508 Reduced 7.85%
5,960 $724,000
Q1 2023

May 20, 2024

BUY
$135.66 - $197.02 $143,256 - $208,053
1,056 Added 19.51%
6,468 $993,000
Q1 2023

Apr 25, 2023

SELL
$135.66 - $197.02 $43,818 - $63,637
-323 Reduced 4.76%
6,468 $993,000
Q4 2022

Feb 03, 2023

BUY
$118.38 - $210.04 $24,741 - $43,898
209 Added 3.18%
6,791 $1.22 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $91,031 - $149,712
-771 Reduced 10.49%
6,582 $778,000
Q2 2022

Aug 01, 2022

SELL
$117.13 - $176.59 $48,374 - $72,931
-413 Reduced 5.32%
7,353 $1.05 Million
Q1 2022

Apr 28, 2022

BUY
$126.46 - $235.05 $50,457 - $93,784
399 Added 5.42%
7,766 $1.36 Million
Q4 2021

Jan 20, 2022

BUY
$225.82 - $368.51 $275,726 - $449,950
1,221 Added 19.87%
7,367 $1.87 Million
Q3 2021

Nov 02, 2021

BUY
$221.9 - $484.47 $618,435 - $1.35 Million
2,787 Added 82.97%
6,146 $2.37 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $8,703 - $15,743
67 Added 2.04%
3,359 $789,000
Q1 2021

Apr 23, 2021

BUY
$109.18 - $185.98 $185,933 - $316,723
1,703 Added 107.17%
3,292 $431,000
Q4 2020

Feb 02, 2021

BUY
$65.74 - $169.86 $39,706 - $102,595
604 Added 61.32%
1,589 $166,000
Q3 2020

Oct 27, 2020

BUY
$54.34 - $94.85 $15,595 - $27,221
287 Added 41.12%
985 $70,000
Q2 2020

Jul 16, 2020

BUY
$29.67 - $80.0 $1,542 - $4,160
52 Added 8.05%
698 $44,000
Q1 2020

Apr 27, 2020

SELL
$17.78 - $31.58 $26,598 - $47,243
-1,496 Reduced 69.84%
646 $19,000
Q4 2019

Jan 30, 2020

BUY
$13.93 - $21.28 $1,978 - $3,021
142 Added 7.1%
2,142 $42,000
Q3 2019

Nov 01, 2019

SELL
$12.26 - $18.07 $14,712 - $21,684
-1,200 Reduced 37.5%
2,000 $32,000
Q2 2019

Aug 05, 2019

SELL
$13.7 - $28.34 $95,215 - $196,963
-6,950 Reduced 68.47%
3,200 $47,000
Q1 2019

May 01, 2019

BUY
$14.45 - $23.7 $146,667 - $240,555
10,150 New
10,150 $207,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.